 |
Articles: Medical Devices/Products |
Prior Articles
New Study Results Analyzed the Use of KAPIDEX for Nighttime Heartburn in Adults with Non-Erosive GERD
Takeda Pharmaceuticals North America, 10/28/09
FDA Determines VYVANSE was Properly Granted Five-Year Market Exclusivity
Shire, 10/27/09 Dey Launches and Unveils Next-Generation, Needle-Protected EpiPen(R) (Epinephrine) Auto-Injector with Enhanced Patient-Friendly Features
Mylan, 10/27/09 Gileads Aztreonam for Inhalation Solution to be Reviewed by FDA Anti-Infective Drugs Advisory Committee on December 2009
Gilead, 10/27/09
Free full text
CHMP issues positive opinion for Micardis as the first treatment in its class to reduce the risk of cardiovascular morbidity in high CV risk patients
Boehringer Ingelheim, 10/26/09
Free full text
Angiotech Pharmaceuticals Announces Commercial Launch of the Tan EndoGlide™ Endothelium Insertion System in the United States at the American Academy of Ophthalmology Annual Meeting
Angiotech Pharmaceuticals, 10/26/09
Free full text
Hotel Dieu Hospital launches touch-screen kiosks
Canadian Healthcare Technology, 10/26/09
Free full text
Zogenix and astellas announce data published showing the benefits of sumaveltm doseprotm needle-free delivery system
Astellas, 10/23/09
Free full text
CDC Advisory Committee on Immunization Practices Votes for Permissive Use and for Vaccines for Children Funding for GARDASIL for Boys and Young Men
Merck & Co., 10/22/09
Free full text
Cephalon Notified of Generic Filing for Armodafinil Tablets
Cephalon, 10/22/09
Free full text
Mobile App Aids in Obtaining Consent
HealthDataManagement, 10/22/09 Shire Targets Fourth Quarter Filing of BLA for REPLAGAL? for Fabry Disease with U.S. FDA
Shire, 10/22/09 Quest Diagnostics to Offer Ambulatory EHR
HealthDataManagement, 10/22/09 GlaxoSmithKline and Human Genome Sciences announce full presentation at ACR of positive phase 3 study results for BENLYSTA in systemic lupus erythematosus
GlaxoSmithKline, 10/21/09
Free full text
New Data Describe Safety of Subcutaneous Administration of ORENCIA For Patients with Moderate to Severe Rheumatoid Arthritis
Bristol Myers-Squibb Company, 10/21/09
Free full text
Cardinal Health, Orchard Software enter exclusive agreement for laboratory information systems offering
Cardinal Health, 10/21/09
Free full text
ORENCIA Demonstrated Sustained Clinical Response in a Study of Adult Patients with Moderate to Severe Early Rheumatoid Arthritis
Bristol Myers-Squibb Company, 10/20/09
Free full text
Covidien Announces Global Launch of Mallinckrodt TaperGuard Line of Endotracheal Tubes
Covidien, 10/20/09 FDA approves Micardis as the first treatment in its class to reduce the risk of heart attack, stroke, or death from cardiovascular causes in patients at high cardiovascular risk who are unable to take ACE inhibitors
Boehringer Ingelheim, 10/20/09
Free full text
ZonePerfect Indulgence Nutrition Squares Give Chocolate Lovers a Sensible Sweet-Tooth Option
Abbott, 10/20/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
